Showing results (1-10 of 489) with videos related to
Sort By:
Pageof 49
Seminars in Hematology|July 5, 2025
Measurable residual disease monitoring in acute myeloid leukaemia: Techniques, timing and therapeutic implicationsKasper J Croese, Jacqueline Cloos, Jesse M TetteroCancers|June 2, 2021
AML/Normal Progenitor Balance Instead of Total Tumor Load (MRD) Accounts for Prognostic Impact of Flowcytometric Residual Disease in AMLDiana Hanekamp, Jesse M Tettero, Gert J Ossenkoppele, et al.Advances in Experimental Medicine and Biology|September 28, 2018
Circular RNAs in CancerSusanne Lux, Lars BullingerSeminars in Cancer Biology|April 25, 2021
Precision medicine in myeloid malignanciesJörg Westermann, Lars BullingerSeminars in Oncology|February 1, 2012
Array-based cytogenetic approaches in acute myeloid leukemia: clinical impact and biological insightsLars Bullinger, Stefan FröhlingExperimental Hematology|April 22, 2014
Expression profiling of leukemia patients: key lessons and future directionsVelizar Shivarov, Lars BullingerInternational Journal of Laboratory Hematology|July 24, 2024
Immunophenotypic features of early haematopoietic and leukaemia stem cellsTom Reuvekamp, Costa Bachas, Jacqueline CloosCurrent Opinion in Oncology|August 25, 2023
Recent advances in precision medicine for acute myeloid leukemiaAlberto Hernández-Sánchez, Lars BullingerCancer Cell|February 5, 2010
HELP for AML: methylation profiling opens new avenuesLars Bullinger, Scott A ArmstrongSeminars in Oncology|August 12, 2008
Gene expression with prognostic implications in cytogenetically normal acute myeloid leukemiaClaudia D Baldus, Lars BullingerPageof 49